What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Heart failure
Arthur M. Feldman spends much of his time researching Heart failure, Internal medicine, Cardiology, Heart disease and Ejection fraction.
He has included themes like Tumor necrosis factor alpha, Surgery, MEDLINE, Guideline and Disease in his Heart failure study.
His Internal medicine study frequently intersects with other fields, such as Endocrinology.
His Heart disease research includes elements of Clinical endpoint and Survival analysis.
His Ejection fraction study combines topics from a wide range of disciplines, such as Placebo, Clinical trial and Chemotherapy.
His Cardiac resynchronization therapy research focuses on subjects like Implantable defibrillator, which are linked to Multicenter Automatic Defibrillator Implantation Trial, Ventricular dyssynchrony and Cardiac contractility modulation.
His most cited work include:
- Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. (4801 citations)
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation (3376 citations)
- ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult (1920 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Heart failure, Cardiology, Endocrinology and Tumor necrosis factor alpha.
His biological study spans a wide range of topics, including Heart disease, Disease and Intensive care medicine.
His Heart disease research is multidisciplinary, incorporating elements of Circulatory system and Myocardial infarction.
His Cardiac resynchronization therapy, Vesnarinone, Enhanced external counterpulsation and Defibrillation study in the realm of Cardiology interacts with subjects such as In patient.
Arthur M. Feldman interconnects Calcium and Adrenergic receptor in the investigation of issues within Endocrinology.
His Tumor necrosis factor alpha study incorporates themes from Proinflammatory cytokine, Inflammation, Genetically modified mouse and Cytokine.
He most often published in these fields:
- Internal medicine (60.06%)
- Heart failure (53.57%)
- Cardiology (32.79%)
What were the highlights of his more recent work (between 2008-2020)?
- Internal medicine (60.06%)
- Heart failure (53.57%)
- Endocrinology (27.60%)
In recent papers he was focusing on the following fields of study:
Arthur M. Feldman mainly investigates Internal medicine, Heart failure, Endocrinology, Cardiology and Cell biology.
Arthur M. Feldman works on Heart failure which deals in particular with Ejection fraction.
His research in Endocrinology intersects with topics in Phospholemman, Receptor and Sodium-calcium exchanger.
His Heart disease, Cardiac resynchronization therapy and Isosorbide dinitrate study in the realm of Cardiology connects with subjects such as Lead.
His Cell biology research incorporates themes from Molecular biology and Over expression.
As a part of the same scientific study, Arthur M. Feldman usually deals with the Intensive care medicine, concentrating on Hospitalized patients and frequently concerns with Disease progression, Pediatrics, Practice management and Guideline.
Between 2008 and 2020, his most popular works were:
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation (3376 citations)
- 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults (1161 citations)
- Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction (593 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Arthur M. Feldman focuses on Internal medicine, Heart failure, Endocrinology, Cardiology and Myocyte.
His work on Ischemia, Cardiac resynchronization therapy and Defibrillation as part of general Internal medicine research is often related to Uniporter, thus linking different fields of science.
Arthur M. Feldman works in the field of Heart failure, namely Beta blocker.
His Endocrinology research is multidisciplinary, relying on both Inflammation, Receptor, Sodium-calcium exchanger and Cardiac function curve.
His Cardiology study frequently draws connections to other fields, such as Placebo.
His Tumor necrosis factor alpha study integrates concerns from other disciplines, such as Downregulation and upregulation and Cytokine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
